Rick Matthews: Venous Thromboembolism Treatment Isn’t the Same For Everyone
Rick Matthews, Sr. Vascular Consultant at Argon Medical Devices, Inc. and Radiology Instructor at Pima Medical Institute, shared a post on LinkedIn:
”VTE treatment isn’t one-size-fits-all.
When evaluating a patient with DVT, the decision to intervene should start with the fundamentals: anatomy, chronicity, symptom burden, and patient risk.
Technology continues to evolve, but good clinical decision-making still starts with understanding the patient and choosing the right strategy for the individual situation.
The goal isn’t simply to remove clot — it’s to make the right treatment decision for the right patient.
What factors weigh most heavily in your decision-making when evaluating VTE patients?”
Find more posts featuring Rick Matthews on Hemostasis Today.
-
Oct 16, 2026, 16:48Abdul Rahman: Reticulocyte Count and Bone Marrow Activity
-
Oct 16, 2026, 16:44DOAC Adherence in Stroke Patients With Atrial Fibrillation – International Journal of Stroke
-
Oct 16, 2026, 16:22Shannon Farmer: Driving Patient Blood Management Forward in Australia and New Zealand
-
Oct 16, 2026, 16:01Obi Light Ogbonnia: The Greatest Reward Is Changing Lives, Not Winning Awards
-
Oct 16, 2026, 15:18Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs